Aripiprazole added to mood stabilizers for bipolar depression
Part of Mental health clinical trials.
This trial tests whether adding aripiprazole (Abilify) to a mood stabilizer helps people with bipolar disorder who are currently in a major depressive episode. It may help improve depressive symptoms compared with the mood stabilizer alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 69 years old when you sign consent.
- You can understand the study information well enough to agree to take part.
- You are currently taking a mood stabilizer such as lithium or valproic acid.
- You have bipolar I or II disorder and are in a major depressive episode right now.
- Your depression symptom score is high (MADRS 20 or higher) at both the screening and start visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares lithium versus cariprazine to treat an episode of depression in people with bipolar disorder. It may help find which medicine works better and is safer during the acute (active) phase of depression.
This trial tests an experimental pill (ABB-932) for people with bipolar I or II disorder who are currently in a depressive episode. The goal is to see if the drug is safe and helps improve mood.
This trial tests a new medication called ABX-002 as an add-on to your current antidepressant. It's for people with moderate to severe depression who haven't gotten enough help from their current antidepressant alone.
This trial tests if adding a new medicine called milsaperidone can help people with major depression who haven't gotten enough relief from their current antidepressant. It aims to see if the combination works better than the antidepressant alone.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This Phase 2 study tests a medication that works on NMDA receptors to improve depression symptoms in people with bipolar I disorder. It may help if you’re currently in a bipolar depression episode and other mood treatments haven’t fully controlled it.
Hear when a new Depression, Bipolar trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.